These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22727681)

  • 1. Treatment of hepatitis delta chronic infection: HBs antigen quantification may help monitoring, and HBs antigen seroconversion could be the ideal 'end' point of treatment.
    Brichler S; Setshedi M; Renou C
    J Clin Virol; 2012 Sep; 55(1):83-4. PubMed ID: 22727681
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamivudine for chronic delta hepatitis.
    Lau DT; Doo E; Park Y; Kleiner DE; Schmid P; Kuhns MC; Hoofnagle JH
    Hepatology; 1999 Aug; 30(2):546-9. PubMed ID: 10421666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
    Niro GA; Ciancio A; Tillman HL; Lagget M; Olivero A; Perri F; Fontana R; Little N; Campbell F; Smedile A; Manns MP; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2005 Aug; 22(3):227-32. PubMed ID: 16091060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta.
    Ouzan D; Pénaranda G; Joly H; Halfon P
    J Hepatol; 2013 Jun; 58(6):1258-9. PubMed ID: 23318602
    [No Abstract]   [Full Text] [Related]  

  • 5. [Seroconversion of HBs antigen to anti-HBs].
    Ohkoshi S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():88-92. PubMed ID: 15453293
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
    J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral blood.
    Petit PR; Borentain P; Aherfi S; Gérolami R; Colson P
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):e41-e44. PubMed ID: 31892507
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Persistence of hepatitis B virus in children after interferon-alpha therapy despite the seroconversion in HBsAg/anti-HBs system].
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Wojda U; Syczewska M; Socha J; Madalińiski K
    Przegl Epidemiol; 2005; 59(3):641-9. PubMed ID: 16433306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels.
    Shin JW; Jung SW; Park BR; Kim CJ; Eum JB; Kim BG; Jeong ID; Bang SJ; Lee SH; Kim SR; Park NH
    J Viral Hepat; 2012 Oct; 19(10):724-31. PubMed ID: 22967104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with chronic hepatitis B and regression of fibrosis during treatment.
    Chang CY; Martin P; Fotiadu A; Hytiroglou P
    Semin Liver Dis; 2010 Aug; 30(3):296-301. PubMed ID: 20665381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis D: New advances, old challenges.
    Farci P
    Hepatology; 2006 Sep; 44(3):536-9. PubMed ID: 16941704
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of detecting HBV DNA with nested-PCR in the sera from patients with anti-HBs positive].
    Huang LH; Jiang YM; Huang ZH; Wu HY; Yang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):631-2. PubMed ID: 14572352
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.